Exacerbations dans l’asthme : prévention pharmacologique
Tóm tắt
Từ khóa
Tài liệu tham khảo
O’Byrne, 2004, Pharmacologic interventions to reduce the risk of asthma exacerbations, Proc Am Thorac Soc., 1, 105, 10.1513/pats.2306028
Bateman, 2010, Overall asthma control: the relationship between current control and future risk, J Allergy Clin Immunol., 125, 600, 10.1016/j.jaci.2009.11.033
Bai, 2007, Severe exacerbations predict excess lung function decline in asthma, Eur Respir J., 30, 452, 10.1183/09031936.00165106
O’Byrne, 2009, Severe exacerbations and decline in lung function in asthma, Am J Respir Crit Care Med., 179, 19, 10.1164/rccm.200807-1126OC
Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2009; Available from: http://www.ginasthma.org.
Sin, 2004, Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis, JAMA., 292, 367, 10.1001/jama.292.3.367
Li, 1996, Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro, Thorax., 51, 1216, 10.1136/thx.51.12.1216
Wark, 2002, Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma, Eur Respir J., 19, 68, 10.1183/09031936.02.00226302
Pauwels, 2003, Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial, Lancet., 361, 1071, 10.1016/S0140-6736(03)12891-7
Guilbert, 2006, Long-term inhaled corticosteroids in preschool children at high risk for asthma, N Engl J Med., 354, 1985, 10.1056/NEJMoa051378
Hawkins, 2003, Stepping down inhaled corticosteroids in asthma: randomised controlled trial, BMJ., 326, 1115, 10.1136/bmj.326.7399.1115
Wong, 2000, Inhaled corticosteroid use and bone-mineral density in patients with asthma, Lancet., 355, 1399, 10.1016/S0140-6736(00)02138-3
Israel, 2001, Effects of inhaled glucocorticoids on bone density in premenopausal women, N Engl J Med., 345, 941, 10.1056/NEJMoa002304
Hubbard, 2002, Inhaled corticosteroids and hip fracture: a population-based case-control study, Am J Respir Crit Care Med., 166, 1563, 10.1164/rccm.200206-606OC
Malo, 1999, Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone, Eur Respir J., 13, 993, 10.1183/09031936.99.13599399
Molimard, 2008, Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation, Drug Saf., 31, 769, 10.2165/00002018-200831090-00005
Cumming, 1997, Use of inhaled corticosteroids and the risk of cataracts, N Engl J Med., 337, 8, 10.1056/NEJM199707033370102
Garbe, 1998, Association of inhaled corticosteroid use with cataract extraction in elderly patients, JAMA., 280, 539, 10.1001/jama.280.6.539
Garbe, 1997, Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma, JAMA., 277, 722, 10.1001/jama.1997.03540330044033
Girodet, 2008, What is the therapeutic response to corticosteroid in smokers with asthma?, Rev Mal Respir., 25, 185, 10.1016/S0761-8425(08)71516-X
Pedersen, 1996, Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking, Am J Respir Crit Care Med, 153, 1519, 10.1164/ajrccm.153.5.8630596
Chalmers, 2002, Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma, Thorax., 57, 226, 10.1136/thorax.57.3.226
O’Byrne, 2009, The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma, Chest., 136, 1514, 10.1378/chest.09-1049
Myers, 2008, Guidelines for asthma management: a review and comparison of 5 current guidelines, Respir Care., 53, 751
Quon, 2010, Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children, Cochrane Database Syst Rev., CD007524
Ducharme, 2010, Written action plan in pediatric emergency room improves asthma prescribing, adherence and control, Am J Respir Crit Care Med
Warke, 2002, Exhaled nitric oxide correlates with airway eosinophils in childhood asthma, Thorax., 57, 383, 10.1136/thorax.57.5.383
Berry, 2005, Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma, Eur Respir J., 25, 986, 10.1183/09031936.05.00132404
Green, 2002, Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial, Lancet., 360, 1715, 10.1016/S0140-6736(02)11679-5
Smith, 2005, Use of exhaled nitric oxide measurements to guide treatment in chronic asthma, N Engl J Med., 352, 2163, 10.1056/NEJMoa043596
Jayaram, 2006, Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations, Eur Respir J., 27, 483, 10.1183/09031936.06.00137704
Bateman, 2004, Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study, Am J Respir Crit Care Med., 170, 836, 10.1164/rccm.200401-033OC
Martinez, 2005, Safety of long-acting beta-agonists – An urgent need to clear the air, N Engl J Med., 353, 2637, 10.1056/NEJMp058299
Drazen, 2009, Risks of long-acting beta-agonists in achieving asthma control, N Engl J Med., 360, 1671, 10.1056/NEJMe0902057
Kramer, 2009, Balancing the benefits and risks of inhaled long-acting beta-agonists – the influence of values, N Engl J Med., 360, 1592, 10.1056/NEJMp0810561
Mann, 2003, Serious asthma exacerbations in asthmatics treated with high-dose formoterol, Chest., 124, 70, 10.1378/chest.124.1.70
Nelson, 2006, The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol, Chest., 129, 15, 10.1378/chest.129.1.15
Cates, 2008, Regular treatment with salmeterol for chronic asthma: serious adverse events, Cochrane Database Syst Rev., CD006363
Rodrigo, 2009, Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review, Pulm Pharmacol Ther., 22, 9, 10.1016/j.pupt.2008.10.008
Weatherall, 2010, Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy, Thorax., 65, 39, 10.1136/thx.2009.116608
Greening, 1994, Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group, Lancet., 344, 219, 10.1016/S0140-6736(94)92996-3
Pauwels, 1997, Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group, N Engl J Med., 337, 1405, 10.1056/NEJM199711133372001
Woolcock, 1996, Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids, Am J Respir Crit Care Med., 153, 1481, 10.1164/ajrccm.153.5.8630590
Murray, 1999, Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases, Allergy Asthma Proc., 20, 173, 10.2500/108854199778553028
van Noord, 1999, Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma, Thorax., 54, 207, 10.1136/thx.54.3.207
Ind, 2003, Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma, Respir Med., 97, 555, 10.1053/rmed.2003.1483
Gibson, 2005, Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children, Cochrane Database Syst Rev., CD005076
Greenstone, 2005, Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma, Cochrane Database Syst Rev., CD005533
Ni Chroinin, 2009, Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children, Cochrane Database Syst Rev., CD005307
Matz, 2001, Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations, J Allergy Clin Immunol., 107, 783, 10.1067/mai.2001.114709
O’Byrne, 2001, Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma. The OPTIMA Randomized Trial, Am J Respir Crit Care Med, 164, 1392, 10.1164/ajrccm.164.8.2104102
Lalloo, 2003, Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma, Chest., 123, 1480, 10.1378/chest.123.5.1480
Ni Chroinin, 2005, Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma, Cochrane Database Syst Rev., CD005535
O’Byrne, 2008, Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control, Chest., 134, 1192, 10.1378/chest.08-1018
Stempel, 2005, Adherence to asthma controller medication regimens, Respir Med., 99, 1263, 10.1016/j.rmed.2005.03.002
Stoloff, 2004, Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies, J Allergy Clin Immunol., 113, 245, 10.1016/j.jaci.2003.10.011
Lasserson, 2008, Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children, Cochrane Database Syst Rev., CD004106
van Noord, 1996, Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action, Eur Respir J., 9, 1684, 10.1183/09031936.96.09081684
Palmqvist, 1997, Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency, Eur Respir J., 10, 2484, 10.1183/09031936.97.10112489
O’Byrne, 2005, Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma, Am J Respir Crit Care Med., 171, 129, 10.1164/rccm.200407-884OC
Humbert, 2008, Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma, Allergy., 63, 1567, 10.1111/j.1398-9995.2008.01863.x
Partridge, 2006, Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study, BMC Pulm Med, 6, 13, 10.1186/1471-2466-6-13
Bisgaard, 2006, Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma, Chest., 130, 1733, 10.1378/chest.130.6.1733
Rabe, 2006, Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial, Chest., 129, 246, 10.1378/chest.129.2.246
Scicchitano, 2004, Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma, Curr Med Res Opin., 20, 1403, 10.1185/030079904X2051
Vogelmeier, 2005, Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?, Eur Respir J., 26, 819, 10.1183/09031936.05.00028305
Rabe, 2006, Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study, Lancet., 368, 744, 10.1016/S0140-6736(06)69284-2
Bousquet, 2007, Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone, Respir Med., 101, 2437, 10.1016/j.rmed.2007.07.014
Kuna, 2007, Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations, Int J Clin Pract., 61, 725, 10.1111/j.1742-1241.2007.01338.x
Chapman, 2010, Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal, Thorax., 65, 747, 10.1136/thx.2009.128504
Jaeschke, 2008, The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis, Am J Respir Crit Care Med., 178, 1009, 10.1164/rccm.200804-494OC
Cates, 2009, Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events, Cochrane Database Syst Rev., CD007695
Cates, 2009, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events, Cochrane Database Syst Rev., CD006922
Sears, 2009, Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials, Eur Respir J., 33, 21, 10.1183/09031936.00145006
Cates, 2010, Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events, Cochrane Database Syst Rev., CD007694
Malmstrom, 1999, Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group, Ann Intern Med., 130, 487, 10.7326/0003-4819-130-6-199903160-00005
Ducharme, 2003, Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence, BMJ., 326, 621, 10.1136/bmj.326.7390.621
Joos, 2008, Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review, Thorax., 63, 453, 10.1136/thx.2007.081596
Ukena, 1997, Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma, Eur Respir J., 10, 2754, 10.1183/09031936.97.10122754
Evans, 1997, A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma, N Engl J Med., 337, 1412, 10.1056/NEJM199711133372002
Lim, 2000, Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice, Thorax., 55, 837, 10.1136/thorax.55.10.837
Milgrom, 1999, Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group, N Engl J Med., 341, 1966, 10.1056/NEJM199912233412603
Busse, 2001, Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma, J Allergy Clin Immunol., 108, 184, 10.1067/mai.2001.117880
Milgrom, 2001, Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab), Pediatrics., 108, E36, 10.1542/peds.108.2.e36
Soler, 2001, The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics, Eur Respir J., 18, 254, 10.1183/09031936.01.00092101
Holgate, 2004, Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma, Clin Exp Allergy., 34, 632, 10.1111/j.1365-2222.2004.1916.x
Lanier, 2003, Omalizumab is effective in the long-term control of severe allergic asthma, Ann Allergy Asthma Immunol., 91, 154, 10.1016/S1081-1206(10)62170-9
Buhl, 2002, Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma, Eur Respir J., 20, 73, 10.1183/09031936.02.00278102
Humbert, 2005, Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE, Allergy., 60, 309, 10.1111/j.1398-9995.2004.00772.x
Holgate, 2001, Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality, Curr Med Res Opin., 17, 233, 10.1185/030079901753403126
Corren, 2003, Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma, J Allergy Clin Immunol., 111, 87, 10.1067/mai.2003.49
Boulet, 2009, Influence of comorbid conditions on asthma, Eur Respir J., 33, 897, 10.1183/09031936.00121308
Covar, 2005, Medications as asthma triggers, Immunol Allergy Clin North Am., 25, 169, 10.1016/j.iac.2004.09.009
Bueving, 2004, Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial, Am J Respir Crit Care Med., 169, 488, 10.1164/rccm.200309-1251OC
Cates, 2008, Vaccines for preventing influenza in people with asthma, Cochrane Database Syst Rev., CD000364
Park, 1996, Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy, Pediatrics., 98, 196, 10.1542/peds.98.2.196
Juhn, 2008, Increased risk of serious pneumococcal disease in patients with asthma, J Allergy Clin Immunol., 122, 719, 10.1016/j.jaci.2008.07.029
Sheikh, 2002, Pneumococcal vaccine for asthma, Cochrane Database Syst Rev., CD002165
Taramarcaz, 2003, Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis, Cochrane Database Syst Rev., CD003570
Taramarcaz, 2004, The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome, Clin Exp Allergy., 34, 1883, 10.1111/j.1365-2222.2004.02130.x
Sontag, 2003, Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies, Am J Gastroenterol., 98, 987
Sontag, 1990, Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy, Gastroenterology., 99, 613, 10.1016/0016-5085(90)90945-W
Harding, 2000, The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms, Am J Respir Crit Care Med., 162, 34, 10.1164/ajrccm.162.1.9907072
DiMango, 2009, Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity, Am J Respir Crit Care Med., 180, 809, 10.1164/rccm.200904-0625OC
Irwin, 1993, Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol, Chest., 103, 1662, 10.1378/chest.103.6.1662
Gibson, 2003, Gastro-oesophageal reflux treatment for asthma in adults and children, Cochrane Database Syst Rev., CD001496
Littner, 2005, Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms, Chest., 128, 1128, 10.1378/chest.128.3.1128
Kiljander, 2006, Effects of esomeprazole 40mg twice daily on asthma: a randomized placebo-controlled trial, Am J Respir Crit Care Med., 173, 1091, 10.1164/rccm.200507-1167OC
Mastronarde, 2009, Efficacy of esomeprazole for treatment of poorly controlled asthma, N Engl J Med., 360, 1487, 10.1056/NEJMoa0806290
Kiljander, 2010, Effect of esomeprazole 40mg once or twice daily on asthma: a randomized, placebo-controlled study, Am J Respir Crit Care Med., 181, 1042, 10.1164/rccm.200910-1537OC
Howard, 2008, Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers, Pharmacoeconomics., 26, 497, 10.2165/00019053-200826060-00004
Linden, 2010, Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers, Curr Med Res Opin., 26, 549, 10.1185/03007990903542666